Salmeterol administration with concomitant inhaled corticosteroid (ICS) has significantly reduced asthma mortality
In recent years considerable insight has been gained in the optimal management of adult asthma
Usual Adult Dose for Chronic Obstructive Pulmonary Disease -
Each inhalation contains 250 micrograms (mcg) of fluticasone and 50 mcg of salmeterol
The ICS-LABA inhaler replaces albuterol as a rescue inhaler
3%) with as-needed formoterol; 3 were cardiac related, and 1 was caused by severe asthma exacerbation
LAMA, mortality was lower in the salmeterol/fluticasone group when compared to the tiotropium group
Airduo™ Respiclick®: For treatment of asthma: Adults and children 12 years of age and older—1 inhalation 2 times per day (morning and evening)
Use salmeterol only as additional therapy for patients with asthma who are currently taking but are inadequately controlled on an ICS
For safety, LABAs should always be taken in combination with an inhaled corticosteroid (ICS)
79; 95% CI, 0
They indicate low, moderate salmeterol/fluticasone containing products on the market and the products are not interchangeable
FIGURE 1
dose ICS, the preferred treatment is a single inhaler with ICS-formoterol (referred to as single maintenance and reliever therapy, or “SMART”) used both daily and as needed
Initial dose should be based on the patient's asthma severity
ICS and LABAs can be administered individually or by fixed-dose combination inhalers